Topically active steroids for use in interstitial pulmonary fibrosis

Details for Australian Patent Application No. 2009206219 (hide)

Owner DOR BIOPHARMA, INC.

Inventors McDonald, George B.

Agent Fisher Adams Kelly

Pub. Number AU-A-2009206219

PCT Pub. Number WO2009/094641

Priority 61/023,266 24.01.08 US

Filing date 26 January 2009

Wipo publication date 30 July 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

26 August 2010 PCT application entered the National Phase

  PCT publication WO2009/094641 Priority application(s): WO2009/094641

9 September 2010 Alteration of Name

  The name of the applicant has been altered to SOLIGENIX, INC.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009206222-Insufflating access system

2009206218-Cryoprobe clamp having transmurality assessment window